Der er ikke rapporteret om teratogen risiko efter kontrolleret ovarie hyperstimulation under klinisk anvendelse af gonadotropiner. ###>No teratogenic risk has been reported, following controlled ovarian hyperstimulation, in clinical use with gonadotropins.